These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16603757)

  • 21. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Benefits of a preventive psychiatric accompaniment in patients Hepatitis C Virus seropositive (HCV): prospective study concerning 39 patients].
    Lang JP; Meyer N; Doffoel M
    Encephale; 2003; 29(4 Pt 1):362-5. PubMed ID: 14615706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to the treatment of hepatitis C. Patient, provider, and system factors.
    Morrill JA; Shrestha M; Grant RW
    J Gen Intern Med; 2005 Aug; 20(8):754-8. PubMed ID: 16050887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychiatric disorders, HIV infection and HIV/hepatitis co-infection in the correctional setting.
    Baillargeon JG; Paar DP; Wu H; Giordano TP; Murray O; Raimer BG; Avery EN; Diamond PM; Pulvino JS
    AIDS Care; 2008 Jan; 20(1):124-9. PubMed ID: 18278623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychiatric management of the hepatitis C patient.
    Rifai MA; Indest D; Loftis J; Hauser P
    Curr Treat Options Gastroenterol; 2006; 9(6):508-19. PubMed ID: 17081484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis C treatment eligibility among HIV-hepatitis C virus coinfected patients in Oregon: a population-based sample.
    Maier MM; He H; Schafer SD; Ward TT; Zaman A
    AIDS Care; 2014; 26(9):1178-85. PubMed ID: 24601687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C screening and treatment outcomes in patients with substance use/dependence disorders.
    Rifai MA; Moles JK; Lehman LP; Van der Linden BJ
    Psychosomatics; 2006; 47(2):112-21. PubMed ID: 16508022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The spectrum of chronic hepatitis C virus infection in the Virginia Correctional System: development of a strategy for the evaluation and treatment of inmates with HCV.
    Sterling RK; Brown RS; Hofmann CM; Luketic VA; Stravitz RT; Sanyal AJ; Contos MJ; Mills AS; Smith V; Shiffman ML
    Am J Gastroenterol; 2005 Feb; 100(2):313-21. PubMed ID: 15667488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis C and substance use: new treatments and novel approaches.
    North CS; Hong BA; Kerr T
    Curr Opin Psychiatry; 2012 May; 25(3):206-12. PubMed ID: 22395769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of hepatitis C treatment and human immunodeficiency virus (HIV) co-infection on the disease burden of hepatitis C among injecting drug users in Amsterdam.
    Matser A; Urbanus A; Geskus R; Kretzschmar M; Xiridou M; Buster M; Coutinho R; Prins M
    Addiction; 2012 Mar; 107(3):614-23. PubMed ID: 21919987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-based hepatitis C treatment in patients with pre-existing severe mental illness and substance use disorders.
    Freedman K; Nathanson J
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):363-76. PubMed ID: 19344248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low incidence of reinfection with the hepatitis C virus following treatment in active drug users in Amsterdam.
    Grady BP; Vanhommerig JW; Schinkel J; Weegink CJ; Bruisten SM; Lindenburg CE; Prins M
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1302-7. PubMed ID: 22825643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus infection and haemodialysis: experience of a district general hospital in Brunei Darussalam.
    Chong VH; Zinna HS
    Singapore Med J; 2008 Nov; 49(11):916-20. PubMed ID: 19037559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study.
    Rogal SS; Arnold RM; Chapko M; Hanusa BV; Youk A; Switzer GE; Sevick MA; Bayliss NK; Zook CL; Chidi A; Obrosky DS; Zickmund SL
    PLoS One; 2016; 11(2):e0148596. PubMed ID: 26900932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychiatric care of the patient with hepatitis C: a review of the literature.
    Rifai MA; Gleason OC; Sabouni D
    Prim Care Companion J Clin Psychiatry; 2010; 12(6):. PubMed ID: 21494349
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Why Me?" Understanding the HCV Care Continuum Among People With Serious Mental Illness.
    Arnold RM; Machover H; Wall ME; Ahmadizadeh I; Potts W; Himelhoch S
    Psychiatr Serv; 2018 Nov; 69(11):1188-1190. PubMed ID: 30220243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The neuropsychiatric aspect of the HCV infection.
    Więdłocha M; Marcinowicz P; Sokalla D; Stańczykiewicz B
    Adv Clin Exp Med; 2017; 26(1):167-175. PubMed ID: 28397449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engaging the Community in Designing a Hepatitis C Virus Treatment Program for Adults Experiencing Homelessness.
    Nyamathi AM; Wall SA; Yadav K; Shin SS; Chang A; Arce N; Cuellar H; Fernando S; White K; Gelberg L; Salem BE
    Qual Health Res; 2021 Sep; 31(11):2069-2083. PubMed ID: 34189974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.